Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4

Cell

Volumn 87, Issue 3, 1996, Pages 543-552

  Ophoff, Roel A ^a,b   Terwindt, Gisela M ^b   Vergouwe, Monique N ^a,b   Van Eijk, Ronald ^a,b   Oefner, Peter J ^c   Hoffman, Susan M G ^d,h   Lamerdin, Jane E ^d   Mohrenweiser, Harvey W ^d   Bulman, Dennis E ^e   Ferrari, Maurizio ^f   Haan, Joost ^b   Lindhout, Dick ^g   Van Ommen, Gert Jan B ^a   Hofker, Marten H ^a   Ferrari, Michel D ^b   Frants, Rune R ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c STANFORD UNIVERSITY   (United States)

^d LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^e LONDON HEALTH SCIENCES CENTRE   (Canada)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^h MIAMI UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; DINUCLEOTIDE; TRINUCLEOTIDE;

ANIMAL TISSUE; ARTICLE; ATAXIA; CONTROLLED STUDY; EXON; FAMILIAL DISEASE; GENE DISRUPTION; GENE MUTATION; GENETIC POLYMORPHISM; HEMIPLEGIA; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MIGRAINE; MISSENSE MUTATION; MOUSE; NONHUMAN; NUCLEOTIDE REPEAT; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DOMAIN; RHESUS MONKEY;

ANIMALIA; ATAXIA; MACACA MULATTA;

EID: 16044370232     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81373-2     Document Type: Article

References (49)

1. Altura, B.M. (1985). Calcium antogonist properties of magnesium: implications for antimigraine actions. Magnesium 4, 169-175.
2. Browne, D.L., Gancher S.T., Nutt, J.G., Brunt, E.R., Smith, E.A., Kramer, P., and Litt, M. (1994). Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat. Genet. 8, 136-140.
3. Buckler, A.J., Chang, D.D., Graw, S.L., Brook, J.D., Haber, D.A., Sharp, P.A., and Housman, D.E. (1991). Exon amplification: a strategy to isolate mammalian genes based on RNA splicing. Proc. Natl. Acad. Sci. USA 88, 4005-4009.
4. Campbell, K.P., Leung, A.T., and Sharp, A.H. (1988). The biochemistry and molecular biology of the dihydropyridine-sensitive calcium channel. Trends Neurosci. 11, 425-430.
5. Cannon, S.C. (1996) Ion-channel defects and aberrant excitability in myotonia and periodic paralysis. Trends Neurosci. 19, 3-10.
6. Chomczynski, P., and Sacchi, N. (1987). Single step method of RNA isolation by acid guanidium thiocyanate phenol chloroform extraction. Anal. Biochem. 162, 156-159.
7. Codignola, A., Tarroni, P., Clementi, F., Pollo, A., Lovallo, M., Carbone, E., and Sher, E. (1993). Calcium channel subtypes controlling serotonin release from human small cell lung carcinoma cell lines. J. Biol. Chem. 268, 26240-26247.
8. De Waard, M., Gurnett, C.A., and Campbell, K.P. (1996). Structural and functional diversity of voltage-activated calcium channels. In Ion Channels, Volume 4, T. Narahashi, ed. (New York: Plenum Press).
9. 2+ channel subunits. Genomics 30, 605-609.
10. Elliott, M.A., Peroutka, S.J., Welch, S., and May, E.F. (1996). Familial Hemiplegic Migraine, nystagmus, and cerebellar atrophy. Ann. Neurol. 39, 100-106.
11. Ferrari, M.D., and Saxena, P.R. (1993). On serotonin and migraine: a clinical and pharmacological review. Cephalalgia. 13, 151-165.
12. Ferrari, M.D., and Saxena, P.R. (1995). 5-HT1 receptors in migraine pathophysiology and treatment. Eur. J. Neurol. 2, 5-21.
13. Ferrari, M.D., Odink, J., Tapparelli, C., Van Kempen, G.M., Pennings, E.J., and Bruyn, G.W. (1989). Serotonin metabolism in migraine. Neurology 39, 1239-1242.
14. Griggs, R.C., and Nutt, J.G. (1995). Episodic ataxias as channelopathies. Ann. Neur. 37, 285-286.
15. Guy, H.R., and Durell, S.R. (1996). Three-dimensional models of ion channel proteins. In Ion Channels, Volume 4, T. Narahashi, ed. (New York, Plenum Press).
16. Haan, J., Terwindt, G.M., and Ferrari, M.D. (1996). Genetics of migraine. In Advances in Headache, N.T. Mathew, ed. (Philadelphia, PA: W.B. Saunders), in press.
17. Hayward-Lester, A., Chilton, B.S., Underhill, P.A., Oefner, P.J., and Doris, P.A. (1996) Quantification of specific nucleic acids, regulated RNA processing and genomic polymorphisms using reversed-phase HPLC. In Gene Quantification, F. Ferr, ed. (Basel, Switzerland: Birkhuser Verlag).
18. Headache Classification Committee of the International Headache Society (1988). Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8, 19-28.
19. Huber, C.G., Oefner, P.J., and Bonn, G.K. (1995) Rapid and accurate sizing of DNA fragments by ion-pair chromatography on alkylated nonporous poly(styrene-divinylbenzene) particles. Anal. Chem. 67, 578-585.
20. Huntington's Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
21. Hudson, A.J., Ebers, G.C., and Bulman, D.E. (1995). The skeletal muscle sodium and chloride channel diseases. Brain 118, 547-563.
22. Joutel, A., Bousser, M-G., Biousse, V., Labauge, P., Chabriat, H., Nibbio, A., Maciazek, J., Meyer, B., Bach, M.A., Weissenbach, J., et al. (1993). A gene for familial hemiplegic migraine maps to chromosome 19. Nature Genet. 5, 40-45.
23. Joutel, A., Ducros, A., Vahedi, K., Labauge, P., Delrieu, O., Pinsard, N., Mancini, J., Ponsot, G., Gouttiere, F., Gastaut, J.L., et al. (1994). Genetic heterogeneity of familial hemiplegic migraine. Am. J. Hum. Genet. 55, 1166-1172.
24. Jurkatt-Rott, K., Lehman-Horn, F., Elbaz, A., Heine, R., Gregg, R.G., Hogan, K., Powers, P.A., Lapie, P., Val-Santos, J.E., Weissenbach, J., et al. (1994). A calcium channel mutation causing hypokalemic periodic paralysis. Hum. Mol. Genet. 3, 1415-1419.
25. Kramer, P.L., Yue, Q., Gancher, S.T., Nutt, J.G., Baloh, R., Smith, E., Browne, D., Bussey, K., Lovrien, K., Nelson, S., and Litt, M. (1995). A locus for the nystagmus-associated form of episodic ataxia maps to an 11-cM region on chromosome 19p. Am. J. Hum. Genet. 57, 182-185.
26. Lauritzen, M. (1996). Pathophysiology of the migraine aura. Sci. Med. 3, 32-41.
27. Margolis, R.L., Breschel, T.S., Li, S.H., Kidwai, A.S., Antonarakis, S.E., McInnis, M.G., Ross, C.A. (1995). Characterization of cDNA clones containing CCA trinucleotide repeats derived from human brain. Som. Cell Mol. Genet. 21, 279-284.
28. May, A., Ophoff, R.A., Terwindt, G.M., Urban, C., Van Eijk, R., Haan, J., Diener, H.C., Lindhout, D., Frants, R.R., Sandkuijl, L.A., and Ferrari, M.D. (1995). Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura. Hum. Genet. 96, 604-608.
29. Mori, Y., Friedrich, T., Kim. M.S., Mikami, A., Nakai., J., Ruth, P., Bosse, E., Hofmann, F., Flockerzi, V., Furuichi, T., et al. (1991). Primary structure and functional expression from complementary DNA of a brain calcium channel. Nature 350, 398-402.
30. Moskowitz, M.A. (1992). Neurogenic versus vascular mechanism of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol. Sci. 13, 307-311.
31. Oefner, P.J., and Underhill, P.A. (1995). Comparative DNA sequencing by denaturing high-performance liquid chromatography (DHPLC). Am. J. Hum. Genet. 57 [Suppl.], A266.
32. Ophoff, R.A., Van Eijk R., Sandkuijl, L.A., Terwindt, G.M., Grubben, C.P.M., Haan, J., Lindhout, D., Ferrari, M.D., and Frants, R.R. (1994). Genetic heterogeneity of familial hemiplegic migraine. Genomics 22, 21-26.
33. Ophoff, R.A., Terwindt, G.M., Vergouwe, M.N., Van Eijk, R., Mohrenweiser, H., Litt, M., Hofker, M.H., Ferrari, M.D., and Frants, R.R. (1996). A 3 Mb region for the Familial Hemiplegic Migraine locus on 19p13.1-p13.2; exclusion of PRKCSH as a candidate gene. Eur. J. Hum. Genet., in press.
34. Orita, M., Suzuki, Y., Sekiya, T., and Hayashi, K. (1989). Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5, 874-879.
35. Orr, H.T., Chung, M.Y., Banfi, S., Kwiatkowski, T.J., Servadio, A., Beaudet, A.L., McCall, A.E., Duvick, L.A., Ranum, L.P., and Zoghbi, H.Y. (1993). Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet. 4, 221-226.
36. Peikert, A., Wilimzig, C., and Köhne-Volland, R. (1996). Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 16, 257-263.
37. Ptacek, L.J., George, A.L., Griggs, R.C., Tawil, R., Kallen, R.G., Barchi, R.L., Robertson, M., and Leppert, M.F. (1991). Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 67, 1021-1027.
38. Ptacek, L.J., Tawil, R., Griggs, R.C., Engel, A.G., Layzer, R.B., Kwiecinski, H., McManis, P.G., Santiago, L., Moore, M., Fouad, G., et al. (1994). Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77, 863-868.
39. Ramadan, N.M., Halvorson, H., Vande-Linde, A., Levine, S.R., Helpern, J.A., and Welch, K.M.A. (1989). Low brain magnesium in migraine. Headache 29, 416-419.
40. Ravnik-Glavac, M., Glavac, D., and Dean, M. (1994). Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene. Hum. Mol. Genet. 3, 801-807.
41. Russell, M.B., and Olesen, J. (1995). Increased familial risk and evidence of genetic factor in migraine. Br. Med. J. 311, 541-544.
42. Russell, M.B., Rasmussen B K., Thorvaldsen P., and Olesen J. (1995). Prevalence and sex-ratio of the subtypes of migraine. Int. J. Epidemiol. 24, 612-618.
43. Starr, T.V.B., Prystay, W., and Snutch, T. (1991). Primary structure of a calcium channel that is highly expressed in the rat cerebellum. Proc. Natl. Acad. Sci. USA 88, 5621-5625.
44. Stea, A., Soong, T.W., and Snutch, T.P. (1995). Voltage-gated calcium channels. In Ligand- and Voltage-Gated Ion Channels, R.A. North, ed. (CRC Press), pp. 113-151.
45. Tanabe, T., Takeshima, H., Mikami, A., Flockerzi, V., Takahashi, H., Kangawa, K., Kojima, M., Matsuo, H., Hirose, T., and Numa, S. (1987). Primary structure of the receptor for calcium channel blockers from skeletal muscle. Nature 328, 313-318.
46. Teh, B.T., Silburn, P., Lindblad, K., Betz, R., Boyle, R., Schalling, M., and Larsson, C. (1995). Familial periodic cerebellar ataxia without myokymia maps to a 19-cM region on 19p13. Am. J. Hum. Genet. 56, 1443-1449.
47. Terwindt, G.M., Ophoff, R.A., Haan, J., Frants, R.R., and Ferrari, M.D. (1996). Familial hemiplegic migraine: a clinical comparison of families linked and unlinked to chromosome 19. Cephalagia 16, 153-155.
48. Von Brederlow, B., Hahn, A.F., Koopman, W.J., Ebers, G.C., and Bulman, D. (1995). Mapping the gene for acetozolamide responsive hereditary paroxysmal cerebellar ataxia to chromosome 19p. Hum. Mol. Genet. 2, 279-284
49. Zhang, A., Cheng, T.P.O., and Altura, B.M. (1992). Magnesium regulates intracellular free ionized calcium concentration and cell geometry in vascular smooth muscle cell. Biochem. Biophys. Acta 1134, 25-29.